在阿姆洛迪平因过量服用时使用芬伊莱弗林,用于耐阻性低血压和非心脏性肺:一个病例报告
Samina Samina1, Pawan Kumar2, Kajal Bai3
1Medicine, Jinnah Sindh Medical University, Karachi, PAK.
过量服用阿姆洛迪平可以导致严重的低血压和肺. 烯在一个案例研究中有效治疗了低血压,但由于潜在的肺胀恶化,建议谨慎使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 关键护理医学 关键护理医学
背景情况:
- 阿姆洛迪平是一种广泛使用的抗高血压药物.
- 过量服用阿姆洛迪平可以导致危及生命的并发症,如耐性低血压和非心脏性肺.
- 严重的阿姆洛迪平过量剂量的管理存在重大临床挑战.
研究的目的:
- 报告一例严重的阿姆洛迪平过量服用病例.
- 评估阿姆洛迪平过量服用时耐火性低血压和肺的管理策略.
- 评估烯在治疗阿姆洛迪平诱导的低血压中的疗效和安全性.
主要方法:
- 一个年轻妇女的病例报告,过量服用了70毫克的阿姆洛迪平.
- 最初的重症监护病房 (ICU) 管理包括静脉注射液体,糖酸和北上腺素.
- 随后的治疗包括用非来治疗低血压和用氧/化物治疗肺.
主要成果:
- 该患者出现了耐火性低血压和非心脏性肺水腫.
- 最初用液体,和上腺素治疗的反应不佳.
- 烯的使用改善了血压,但暂时恶化了肺.
- 患者最终在支持性护理下康复,并在第五天出院.
结论:
- 烯可能是一个有价值的治疗耐药性低血压在阿姆洛迪平过量服用.
- 在使用血管压缩剂时,仔细监测肺是至关重要的,如在过量服用阿姆洛迪平时使用非尼勒.
- 这一案例凸显了严重的阿姆洛迪平毒性的复杂管理.
更多相关视频
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
相关概念视频
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Cardiopulmonary Resuscitation III: AED Use
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
